Indian Ramipril Exporters: Complete Supplier Ranking with Market Share — 389 Manufacturers (2026) — TransData Nexus

Q: Who is the largest ramipril buyer importing from India?

CSP VIATRIS SANTE AT CSP- LAB, (FRANCE) is the largest ramipril importer from India with a 8.4% market share and import value of $7.5M.

Q: How many ramipril buyers import from India?

There are 389 active ramipril buyers importing from India, with a combined import market of $89.8M across 4,977 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top ramipril buyers from India?

The top 5 ramipril buyers — CSP VIATRIS SANTE AT CSP- LAB,, WOCKHARDT UK LIMITED, CRESCENT PHARMA LTD, BROWN AND BURK UK LIMITED, MILPHARM LIMITED, — together control 31.1% of total ramipril import value from India.

Suresh Sormare

Ramipril

India Pharmaceutical Trade Intelligence

$89.8M177 Suppliers93 CountriesHS 30049071

ExportsIndia → UNITED KINGDOM35.0%India → FRANCE23.2%

ImportsMALTA → India$520.7K GERMANY → India$469.4K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: CSP VIATRIS

Market Analysis: Top Importing Countries & Their Importers

1United Kingdom

United Kingdom emerges as the first largest importing country, achieving a total trade value of $31.4M through 1,063 shipments. This represents a market share of 35.0% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United Kingdom has a diverse importer base, with their top importers including:

• WOCKHARDT UK LIMITED - $6.7M (21.3% of country's total business)

• CRESCENT PHARMA LTD - $5.8M (18.3% of country's total business)

• BROWN AND BURK UK LIMITED - $4.0M (12.6% of country's total business)

• MILPHARM LIMITED, - $3.9M (12.5% of country's total business)

• M/S CRESCENT PHARMA LTD. - $3.1M (9.8% of country's total business)

• Rest of United Kingdom's importers - $8.0M (25.5% of country's total business)

Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $29.6K, indicating premium pricing strategy compared to the market average of $18.0K.

United Kingdom is a key market for Ramipril imports, representing 35.0% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Ramipril buyer market intelligence

1Buyer Segment Analysis

The importers of Ramipril from India can be categorized into several key segments:

1. Pharmaceutical Companies: Entities such as CSP Viatris Santé (France), Wockhardt UK Limited, Crescent Pharma Ltd, Brown and Burk UK Limited, Milpharm Limited, and Apotex Inc. (Canada) fall into this category. These companies procure Ramipril in bulk for formulation, packaging, and distribution under their brand names. Their purchasing behavior is characterized by large-volume orders and long-term contracts to ensure a steady supply chain.

2. Contract Manufacturers: Companies like Milpharm Limited and Brown and Burk UK Limited often operate as contract manufacturers, producing Ramipril for other pharmaceutical brands. They typically place consistent, large-scale orders to meet the demands of their clients, adhering to stringent quality and regulatory standards.

3. Distributors: Entities such as Crescent Pharma Ltd and Apotex Inc. function as distributors, supplying Ramipril to various healthcare providers, pharmacies, and hospitals. Their purchasing patterns involve regular, medium to large-sized orders to maintain adequate inventory levels and meet market demand.

4. Re-exporters: Some companies, including CSP Viatris Santé, may act as re-exporters, importing Ramipril from India and then exporting it to other countries. This segment focuses on leveraging cost advantages and regulatory approvals to supply multiple markets, often placing orders based on the demand in their target export destinations.

Each segment's purchasing behavior is influenced by factors such as market demand, regulatory requirements, and strategic business objectives.

Country-Specific Import Regulations

TransData Nexus Ramipril buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Ramipril are as follows:

1. United Kingdom:

Drug Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).

Import Registration Process: Importers must hold a Wholesale Dealer's License and ensure that the imported Ramipril complies with UK and EU Good Manufacturing Practice (GMP) standards.

Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the application and compliance with regulatory requirements.

Import Tariff/Duty for HS 30049071: Pharmaceutical products under HS code 30049071 are generally subject to a 0% import duty in the UK.

2. France:

Drug Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).

Demand Drivers & Market Opportunity

TransData Nexus Ramipril buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Ramipril in importing countries is driven by several key factors:

1. Prevalence of Cardiovascular Diseases: Hypertension and heart failure are leading health concerns globally. According to the "Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023" published in JACC in September 2025, the number of prevalent cases of cardiovascular disease reached 626 million globally in 2023, underscoring the vast and growing patient population requiring management for these conditions.

2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are enhancing their healthcare infrastructure and expanding coverage, leading to increased access to essential medications like Ramipril. For instance, the inclusion of Ramipril in national formularies and reimbursement schemes facilitates its widespread use.

3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Ramipril's inclusion in the World Health Organization's Essential Medicines List underscores its importance in treating cardiovascular conditions. This inclusion often leads to bulk procurement through government tenders, ensuring availability in public healthcare systems.

With 389 buyers across 93 countries, the global reach and consistent demand for Ramipril highlight significant market opportunities. The combination of high disease prevalence, supportive healthcare policies, and established procurement mechanisms positions Ramipril as a critical component in cardiovascular disease management worldwide.

TransData Nexus Research · Government and regulatory sources

Common Questions — Ramipril Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest ramipril buyer importing from India?

Based on import volume and value, CSP VIATRIS SANTE AT CSP- LAB, (FRANCE) leads with $7.5M in imports and a 8.4% market share — the highest of any single ramipril importer. WOCKHARDT UK LIMITED (UNITED KINGDOM) and CRESCENT PHARMA LTD (UNITED KINGDOM) are the next largest buyers.

QHow many companies buy ramipril from India?

There are 389 active ramipril buyers importing from India, with a combined market of $89.8M across 4,977 shipments to 93 countries. The top 5 buyers hold 31.1% of total import value, while the remaining 384 buyers handle the other 68.9%.

QWhich countries import the most ramipril from India?

The top importing countries for ramipril from India are United Kingdom (35.0%), France (23.2%), United States (14.4%), Canada (6.2%), Italy (4.9%). These markets represent the largest demand centres for Indian pharmaceutical exports of ramipril, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for ramipril from India?

The average import transaction value for ramipril from India is $18.0K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Ramipril buyer market intelligence

1Buyer Segment Analysis

The importers of Ramipril from India can be categorized into several key segments:

Each segment's purchasing behavior is influenced by factors such as market demand, regulatory requirements, and strategic business objectives.

Country-Specific Import Regulations

TransData Nexus Ramipril buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Ramipril are as follows:

1. United Kingdom:

Drug Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).

Import Registration Process: Importers must hold a Wholesale Dealer's License and ensure that the imported Ramipril complies with UK and EU Good Manufacturing Practice (GMP) standards.

Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the application and compliance with regulatory requirements.

Import Tariff/Duty for HS 30049071: Pharmaceutical products under HS code 30049071 are generally subject to a 0% import duty in the UK.

2. France:

Drug Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).

Demand Drivers & Market Opportunity

TransData Nexus Ramipril buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Ramipril in importing countries is driven by several key factors:

TransData Nexus Research · Government and regulatory sources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ramipril

Ramipril

Who Buys Ramipril from India — 389 Importers Behind a $89.8M Market

Top Ramipril Importers — Ranked by Import Value

Top Ramipril Buyers & Importers

Related Analysis

Need Details?

Ramipril — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Ramipril — and from which countries?

Ramipril — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United Kingdom

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Ramipril Buyers & Importers

QWho is the largest ramipril buyer importing from India?

QHow many companies buy ramipril from India?

QWhich countries import the most ramipril from India?

QWhat is the average import order value for ramipril from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2France

3United States

4Canada

5Italy

Analysis Methodology